Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Backers
1
Neva SGR
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
TwoStep11-50 employees
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
CytosolixVenture round $6.6M · 3 yr ago • 11-50 employees
Our Tumor Activated Permeability (TAP) Platform produces weakly-acidic derivatives of known oncology drugs that already work. It preserves…
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
AlixiaVenture round $1.8M · 2 yr ago • Founded 2022 • 1-10 employees
Targeting the Tumor Ecosystem to address cancer drug resistance and improve patients’ lives.
BioSapienSeed $1.8M · 4 yr ago • 11-50 employees
BioSapien's MediChip™ delivers sustained cancer therapy directly at the tumor site while minimizing systemic exposure through localized…
Kumquat BiosciencesVenture round $30M · 5 yr ago • Founded 2018 • 201-500 employees
Innovating life-changing medicines for cancer patients. At Kumquat, we're on a mission to transform cancer treatment by delivering durable…

Overview

BetaGlue Therapeutics — YntraDose®: a one-time, image-guided Yttrium-90 injection designed for durable local tumor control alongside systemic therapy.

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Milan Italy
Regional office
BetaGlue Therapeutics SpA
200-500 est. staff
Via della Moscova, 3 20121 Milan, Italy
company site